City Council Regular Meeting


Print

Return to the Search Page Return to the Agenda
  12.D.       
Meeting Date: 04/07/2021  
From: Chaps Poduri

RECOMMENDATION
Direct City Staff to enter into a memorandum of understanding with Curative, Inc. for COVID-19 testing purposes, and determine an appropriate location on City property to install the Curative COVID-19 testing kiosk.
DISCUSSION
Beginning in February of this year, the City Council has been discussing the possibility of partnering with Curative, Inc. for a proposed COVID-19 testing kiosk to be placed within Pacific Grove.  In these discussions, the City Council had questions as to the opinion of County Health Officer regarding the proposal, and the outcome of the FDA warning regarding alleged Curative false positives for COVID-19.  The City Council wished for responses to these questions prior to moving forward with the proposed memorandum of understanding.

To address the question as to the opinion of the County Health Officer regarding the proposal, inquiries were placed to Dr. Moreno (Monterey County Health Officer), Charles McKee (Monterey County Chief Administrative Officer) and Sarah Hardgrave (Chief of Staff to Monterey County Supervisor Mary Adams).  While Dr. Moreno did not offer an opinion on the proposal, Monterey County is familiar with Curative, Inc., and currently receives COVID-19 PCR results from other Curative sites via the State’s surveillance system.  Mr. McKee opined that Monterey County would not have a concern with the City moving forward with the Curative proposal, as he viewed the testing effort as complimentary and supplemental to existing testing available within Monterey County.  In addition, Sarah Hardgrave communicated that Supervisor Adams is supportive of the City moving forward with this action.

To address outcome of the FDA warning regarding alleged Curative false positives for COVID-19, Shoshana Gould, Regional Partnerships Manager of Curative, Inc. provided the following response:

"FDA issued a Safety Communication on January 4, 2021, about the Curative SARS-CoV-2 Assay and the potential risk of false negatives for our test, consistent with our FDA authorized labeling. Curative's test has been validated and is being offered during the pandemic under an Emergency Use Authorization, and is labeled with specific warnings, precautions, and limitations that FDA reiterated in the Safety Communication. The test performance and labeling, however, have not changed, nor has the company observed any changes in test performance. We have been working with the agency to address their concerns and these limitations, and we will continue to work interactively with FDA through the Emergency Use Authorization process." 
OPTIONS
1.  Take no action
2.  Provide alternate direction
FINANCIAL IMPACT:
While there is no financial impact for entering into a memorandum of understanding for COVID-19 testing with Curative, Inc., there will be a minor amount of City staff work required related to the citing and placement of the COVID-19 testing kiosk.  
  
GOAL ALIGNMENT: Community Responsiveness: Develop and implement systems, interfaces and infrastructure.
Attachments
MOU


    

Level double AA conformance,
                W3C WAI Web Content Accessibility Guidelines 2.0

AgendaQuick ©2005 - 2021 Destiny Software Inc. All Rights Reserved.